about
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and int...
Read More
0.63
0.00
(0.00%)
235.2K
XNAS Volume
XNAS 19 Dec, 2025 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
Scynexis Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..